Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Eur J Endocrinol. 2018 Jan 12;178(3):255–263. doi: 10.1530/EJE-17-0873

Table 2.

Comparison of post-operative serum cortisol in patients achieving early remission by POD-10. Results of AUROC analyses with recurrence as the reference variable. Remission defined as cortisol nadir ≤5µg/dL. Recurrence defined by biochemical hormone levels, clinical stigmata or medication requirement.

Cortisol AUROC 95% CI Std dev n P value
0000hr POD-1 0.775 0.64, 0.91 0.067 94 0.010**
0600hr POD-1 0.839 0.74, 0.94 0.052 119 <0.001***
1200hr POD-1 0.761 063, 0.89 0.068 103 0.015*
1800hr POD-1 0.724 0.52, 0.93 0.105 98 0.039*
0600hr POD-3 0.742 0.63, 0.85 0.056 228 <0.001***
1200hr POD-3 0.753 0.53, 0.97 0.111 52 0.044*
1800hr POD-3 0.897 0.77, 1.03 0.055 42 0.023*
NEPV cortisol 0.832 0.72, 0.94 0.055 65 0.007**
Nadir ≤5µg/dL 0.714 0.60, 0.83 0.058 241 0.001***
Nadir ≤2µg/dL 0.661 0.51, 0.80 0.073 222 0.050*

(Abbreviations: POD, post-operative day; NEPV, normalised early post-operative value, AUROC, area under the receiver operating curve; CI, confidence interval; Std dev, standard deviation; n, number; p value, probability value).